Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery
2007; Oxford University Press; Volume: 64; Issue: 17 Linguagem: Inglês
10.2146/ajhp060398
ISSN1535-2900
AutoresSarah J. Johnson, Mary B. Ross, Kevin G. Moores,
Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoJournal Article Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery Get access Sarah J. Johnson, Pharm.D., Sarah J. Johnson, Pharm.D. Clinical Pharmacy Specialist Medication Use Evaluation, Department of Pharmaceutical Care, University of Iowa Hospitals and Clinics (UIHC), Iowa City, and Assistant Professor (Clinical), University of Iowa College of Pharmacy (UICP), Iowa City Search for other works by this author on: Oxford Academic Google Scholar Mary B. Ross, B.S.Pharm. M.B.A., Mary B. Ross, B.S.Pharm. M.B.A. Assistant Director Department of Pharmaceutical Care UIHC, and Adjunct Associate Professor, UICP Search for other works by this author on: Oxford Academic Google Scholar Kevin G. Moores, Pharm.D. Kevin G. Moores, Pharm.D. Associate Professor (Clinical) and Director Division of Drug Information Service, UICP Address correspondence to Dr. Moores at the University of Iowa College of Pharmacy, 100 Oakdale Campus, N330OH, Iowa City, IA 52242-5000 (kevin-moores@uiowa.edu). Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, Volume 64, Issue 17, 1 September 2007, Pages 1808–1812, https://doi.org/10.2146/ajhp060398 Published: 01 September 2007
Referência(s)